瑞银发表研究报告指，平安好医生(01833.HK)完成战略2.0转型，预测其2024至2027年收入复合年均增长率将达12.7%，利润率亦有提升空间，该行恢复对其覆盖，予以“中性”评级，目标价从20元下调至16.5元。瑞银预期，凭借平安好医生全面的医疗健康服务及人工智能用户管理能力，平安好医生将持续提升来自平安集团客户渗透率，同时推动每用户平均收入增长，预测经调整净利润率将从2024年的3.3%...
Source Link瑞银发表研究报告指，平安好医生(01833.HK)完成战略2.0转型，预测其2024至2027年收入复合年均增长率将达12.7%，利润率亦有提升空间，该行恢复对其覆盖，予以“中性”评级，目标价从20元下调至16.5元。瑞银预期，凭借平安好医生全面的医疗健康服务及人工智能用户管理能力，平安好医生将持续提升来自平安集团客户渗透率，同时推动每用户平均收入增长，预测经调整净利润率将从2024年的3.3%...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.